Healthpeak Properties, Inc. (DOC)
Real Estate · Health Care REITs · US stock · S&P 500 component
$18.98
▲ +0.02 (0.11%)
Day's range
$18.80 – $19.17
52-week range
$14.96 – $22.72
About Healthpeak Properties, Inc.
Healthpeak Properties is a real estate investment trust that owns and operates healthcare property in the United States. Its portfolio is built around laboratory and life science buildings, outpatient medical offices and senior living communities, including continuing care retirement communities. Tenants include biotechnology and pharmaceutical firms, health systems, physician groups and senior living operators.
Income comes mainly from rent and related charges paid by tenants. Revenue is $2.9 billion over the last twelve months, rising 11.0% a year across the last three years. The operating margin is 26.5%, and the business earns a profit of 4% on the capital invested in it. Healthpeak carries net debt of 4.6 times EBITDA, and the dividend yield is 6.4%. On the site's X-Ray Score it receives 37 out of 100.
Written with AI from public information and the filing figures on this page, then checked automatically for unsupported numbers. It can contain mistakes: read the company's own filings below before relying on it.
Price chart
52-wk range $14.96 – $22.72Volume 5,638,100Daily, split-adjusted
Vitals
Market cap$13.1B
52-week range$14.96 – $22.72
Volume (last day)5,638,100
P/E (TTM)54.1
EBIT / EV yield3.3%
Free-cash-flow yield–
Dividend yield6.4%
Revenue (TTM)$2.9B
Net income (TTM)$243M
Operating margin26.5%
Return on capital4.3%
Debt incl. leases$10.3B
Cash & securities$1.6B
Debt = borrowings plus lease liabilities. Cash & securities = cash, equivalents and short-term marketable securities (long-term securities are not counted, so net cash can be understated for companies like Apple). Net debt = debt minus cash & securities. Source: latest SEC 10-Q/10-K. EBIT / EV yield = operating profit divided by market cap plus net debt.
Fair value estimate
Not rated
REIT valuation (FFO multiples + DDM) not built yet: not rated
What this means
Read the lenses below
A high score does not guarantee a good outcome; it shifts the odds a little. Use the checklist as a prompt for your own research.
Before you invest · decision checklist
Ticked boxes are filled in from our data; the rest are yours to answer.
The five-lens scan
Every score explained in one sentence, ranked against Real Estate peers. Open a lens to see the numbers behind it.
Valuation
Weak
35/100
Expensive against its sector on earnings and cash flow.
See the numbers →
EBIT / EV yield3.3%
Growth
Weak
38/100
Growing slower than most of its sector.
See the numbers →
Revenue growth (3y)11.0%
EPS growth (3y)-52.3%
Growth consistency90%
Profitability
Weak
42/100
Earns lower returns on its capital than most peers.
See the numbers →
Return on invested capital4.3%
Operating margin26.5%
Financial health
Weak
23/100
Balance sheet is more stretched than most peers.
See the numbers →
Piotroski F-Score4 / 9
Net debt / EBITDA4.6×
Interest cover2.3×
Dividends
Fair
57/100
Dividend is typical for its sector.
See the numbers →
Dividend yield6.4%
Dividend growth9.4%
Quarterly results: last 6 quarters
+15.9%
Mar '25
-0.2%
Jun '25
+0.8%
Sep '25
+3.1%
Dec '25
+7.1%
Mar '26
+11.1%
Jun '26
Revenue against the same quarter a year earlier. Latest quarter revenue $772M, diluted EPS $0.08.
Compare with peers
WELL Welltower Inc.47 VTR Ventas, Inc.47Other Health Care REITs companies by X-Ray Score.
Fundamentals checklist
● 2 Good · ● 3 Average · ● 5 BadCash quality
Earnings backed by cashGood
Risk models
Piotroski F-ScoreBad
Growth
EPS growth (3y)Bad
Revenue growth (3y)Good
Growth consistencyBad
Balance sheet
Net debt / EBITDAAverage
Interest coverBad
Valuation
EBIT / EV yieldAverage
Profitability
Return on invested capitalBad
Operating marginAverage
Each check is graded against the company's sector, not a fixed number. Checklist score 38/100.
Financials
| FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Revenue | $1.9B | $2.1B | $2.2B | $2.7B | $2.8B |
| Operating income | $286M | $680M | $515M | $554M | $589M |
| Net income | $506M | $500M | $306M | $243M | $71M |
| Operating cash flow | $795M | $900M | $956M | $1.1B | $1.3B |
| Operating margin | 15.1% | 33.0% | 23.6% | 20.5% | 20.9% |
| Free cash flow | $36M | −$62M | $182M | $334M | $357M |
| Diluted EPS | $0.93 | $0.92 | $0.56 | $0.36 | $0.10 |
Fiscal years, from SEC filings.
Technical summary
Daily
Bearish
2 bullish · 4 neutral · 10 bearish
Weekly
Neutral
6 bullish · 1 neutral · 5 bearish
Monthly
Strongly bullish
6 bullish · 1 neutral · 1 bearish
Moving averages (daily)
| SMA 10 | 18.84 | Bullish |
| EMA 10 | 19.03 | Bearish |
| SMA 20 | 19.50 | Bearish |
| EMA 20 | 19.37 | Bearish |
| SMA 50 | 20.22 | Bearish |
| EMA 50 | 19.95 | Bearish |
| SMA 100 | 20.52 | Bearish |
| EMA 100 | 19.86 | Bearish |
| SMA 200 | 18.64 | Bullish |
| EMA 200 | 19.12 | Bearish |
Oscillators (daily)
| RSI (14) | 38.16 | Neutral |
| MACD (12, 26) | -0.45 | Bearish |
| Momentum (12) | -4.96 | Bearish |
| Stochastic %K (14) | 33.16 | Neutral |
| Williams %R (14) | -66.84 | Neutral |
| CCI (20) | -54.11 | Neutral |
Pivot points (classic, last session)
S3 18.43 | S2 18.61 | S1 18.80 | Pivot 18.98 | R1 19.17 | R2 19.35 | R3 19.54 |
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
1.22 USD
Yield on today's price
6.45%
Frequency
Monthly
Next ex-dividend date
13 Nov 2026
| Ex-dividend date | Amount per share |
|---|---|
| 18 Dec 2026 (upcoming) | 0.1017 |
| 13 Nov 2026 (upcoming) | 0.1017 |
| 19 Oct 2026 | 0.1017 |
| 14 Sep 2026 | 0.1020 |
| 17 Aug 2026 | 0.1020 |
| 20 Jul 2026 | 0.1020 |
| 15 Jun 2026 | 0.1020 |
| 18 May 2026 | 0.1020 |
| 17 Apr 2026 | 0.1020 |
| 17 Mar 2026 | 0.1020 |
| 13 Feb 2026 | 0.1020 |
| 16 Jan 2026 | 0.1020 |
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
DOC SEC filings
5 Aug 2026
10-QSEC EDGAR
Quarterly report
4 Aug 2026
8-KSEC EDGAR
Results of operations; Regulation FD disclosure
6 May 2026
10-QSEC EDGAR
Quarterly report
5 May 2026
8-KSEC EDGAR
Results of operations; Regulation FD disclosure
4 May 2026
8-KSEC EDGAR
Shareholder vote results
23 Mar 2026
8-KSEC EDGAR
Entered a material agreement
12 Mar 2026
DEF 14ASEC EDGAR
Proxy statement
27 Feb 2026
8-KSEC EDGAR
Regulation FD disclosure
Where the numbers come from
Statements SEC EDGAR filings (10-K, 10-Q), quarters derived from year-to-date figures.
Prices end-of-day closes, split-adjusted.
Industry inputs beta, multiples and equity risk premium from Damodaran Online (NYU Stern).
StocksXray is for education only and is not financial advice. Scores and fair values are model estimates from public filings and carry uncertainty.